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Integrin-Mediated Transcriptional Activation of Inhibitor of
Apoptosis Proteins Protects Smooth Muscle Cells Against
Apoptosis Induced by Degraded Collagen
Karin von Wnuck Lipinski, Petra Keul, Nicola Ferri, Susann Lucke, Gerd Heusch,
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Abstract—Apoptosis of smooth muscle cells (SMC) and degradation of the extracellular matrix (ECM) have both been
implicated in atherosclerotic plaque rupture. We have previously reported that degraded type I collagen fragments
induce a rapid but transient apoptotic burst initiated by calpains in SMC. The aim of the current study was to identify
the pathway responsible for consecutive SMC survival. We show that exposure of SMC to collagen fragments resulted
in a sustained activation of nuclear factor (NF)-B via phosphorylation and degradation of IB. Its prevention through
retroviral expression of superrepressor IB or proteasome inhibition potently induced apoptosis. In the presence of
blocking antibodies to v3 integrin and RGD peptides, collagen fragments no longer activated NF-B and apoptosis
was enhanced. The mechanism by which NF-B was protecting SMC against collagen fragment-induced apoptosis was
a transcriptional activation of several endogenous caspase inhibitors of the inhibitor of apoptosis protein (IAP) family
as: (1) the expression of xIAP, c-IAP2, and survivin was potently induced by collagen fragments; (2) IAP expression
was abrogated by superrepressor IB; and (3) knockdown of each of the 3 IAPs by small interfering RNA (siRNA)
resulted in enhanced apoptosis after collagen fragment treatment. Our data suggest that SMC exposed to degraded
collagen are protected against apoptosis by a mechanism involving v3-dependent NF-B activation with consequent
activation of IAPs. This may constitute a novel antiapoptotic pathway ensuring SMC survival in settings of enhanced
ECM degradation such as cell migration, vascular remodeling, and atherosclerotic plaque rupture. (Circ Res.
2006;98:1490-1497.)
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Extracellular matrix (ECM) remodeling plays a major rolein the pathogenesis of atherosclerosis and restenosis.1
Smooth muscle cells (SMC) both synthesize and degrade the
surrounding ECM,2 the composition and integrity of which is
viewed as a crucial determinant of plaque stability. The major
ECM components synthesized and deposited by SMC in the
plaque are type I and III collagens.3 These collagens are
proteolytic substrates for several metalloproteinases (MMPs)
such as MMP-1, -2, -8, -9, and -13 and MT1-MMP that are
produced and secreted by plaque SMC and macrophages.
Although the degradation of fibrous cap collagens has been
widely implied in plaque rupture through its mere mechanical
destabilization,4 little is known about the biological role of
the resulting collagen degradation products. As collagen
degradation and SMC apoptosis coincide at sites of plaque
rupture and have both been implied in its pathogenesis,5,6 we
hypothesized that there may be a link between the 2 pro-
cesses. Collagen degradation products are by no means inert
in respect to apoptosis: in endothelial cells, proteolytic
fragments of type IV collagen (endostatin) and XVIII colla-
gen (tumstatin) potently induce apoptosis,7,8 whereas in rat
vascular SMC, type I collagen fragments inhibit apoptosis
through the production of the survival factor tenascin-C.9
Our previous studies have shown that extended culture of
human SMC on polymerized type I collagen profoundly
altered their focal contacts through calpain-mediated proteol-
ysis of focal adhesion proteins such as FAK, talin, and
paxillin and that this process was mediated by MMP-
generated collagen fragments.10 Recently, we demonstrated
that the identical collagen fragments lead to a rapid activation
of caspases and apoptosis that was dependent on calpains.11
This coincided with calpain-dependent proteolysis of X
chromosome–linked inhibitor of apoptosis protein (xIAP)
resulting in loss of its caspase-inhibitory potential.11 How-
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ever, caspase activation was moderate, xIAP destruction
transient and most of the SMC survived. This led us to
postulate the existence of an antiapoptotic pathway activated
in parallel by type I collagen fragments and dominant over
the apoptotic. In the present study, we have identified this
survival pathway as the activation of the transcription factor
nuclear factor (NF)-B by type I collagen fragments with
consecutive activation of several members of the inhibitor of
apoptosis (IAP) family. We have characterized the necessity
and sufficiency of the IAPs for SMC survival in a proteolyzed
collagen environment and have identified the responsible
integrins.
Materials and Methods
Reagents and Antibodies
The following antibodies were used for immunoblotting: xIAP,
poly(ADP-ribosyl) polymerase (PARP) (BD Biosciences),
c-IAP2, IB (Santa Cruz Biotechnology); p-I, cleaved
caspase-3, cleaved lamin A (New England Biolabs); survivin
(Novus Biologicals); caspase-3 (R&D Systems); - and -actin
(Sigma-Aldrich); and GAPDH (HyTest Ltd). Other reagents used
were: secondary antibodies (Vector Laboratories); blocking anti-
body against vb3 (LM609; Chemicon); mouse IgG1 (BD Bio-
sciences); RGD peptides (Invitrogen); N-acetyl-leucinyl-leucinyl-
norleucinal (LLnL) and Z-Leu-Leu-Leu-aldehyde (MG-132;
Alexis); and cycloheximide (Sigma-Aldrich).
SMC Culture and Preparation of
Collagen Fragments
Human newborn arterial SMC from the thoracic aorta were a kind
gift of Elaine W. Raines, University of Washington, Seattle, and
were used in all our previous studies on collagen fragments.10,11
Type I collagen gels (1.0 mg/mL final collagen concentration) were
prepared by neutralizing the bovine skin collagen solution (Vitrogen
100, Cohesion) with one-sixth volume of a 7-fold DMEM and
polymerization at 37°C for 12 hours. Collagen-coated dishes were
prepared by incubating 0.1 mg/mL collagen solution in 0.1 mol/L
acetic acid at 37°C for 12 hours. Degraded type I collagen was
prepared as described10,11 by incubating polymerized collagen gels
with 2 mg/mL collagenase type 3 (Worthington Biochemical Corp)
at 37°C for 30 minutes and addition of an equal volume of 10%
FCS/DMEM.
Figure 1. Degraded collagen fragments
induce apoptosis in human SMC in the
presence of cycloheximide and protea-
some inhibition, respectively. A, SMC
were exposed to degraded type I colla-
gen fragments (250 g/mL) in the pres-
ence and absence of 10 g/mL cyclo-
heximide or 50 mol/L LLnL for the
indicated times. Apoptosis was assessed
by flow cytometric analysis after double
staining with FITC-labeled annexin V and
PI. One representative experiment of 3 is
shown. Bar graphs represent mean
valuesSD from all experiments. ANOVA
was used to compare 24 hours of colla-
gen fragment treatment with 6 hours and
control.*P0.05 vs untreated controls. In
a separate ANOVA, 24 hours of collagen
fragment treatment with and without in-
hibitors was compared. #P0.05 vs
SMC incubated with collagen fragments
without inhibitors for 24 hours. NS indi-
cates not significantly different from con-
trol. B and C, Apoptosis was evaluated
by Western blot analysis using antibod-
ies against active caspase-3, PARP, and
cleaved lamin A/C. Expression of -actin
or pro–caspase-3 were used as loading
controls. Shown are representative
experiments of 4. D, Quantification of
caspase-3 activation is represented as
fold increase after densitometric analysis
by NIH image. Results are the meanSD
of 4 independent experiments. Statistical
analysis was performed as in Figure 1A.
*P0.05 vs untreated controls. #P0.05
vs SMC incubated with collagen frag-
ments without inhibitors for 24 hours.
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Protein Analysis
Cells were lysed in 50 mmol/L Tris-HCl, pH 8.0, 250 mmol/L NaCl,
5 mmol/L EDTA, pH 8.0, 50 mmol/L NaF, 0.5% Nonidet P-40
[NP-40], 0.5 mmol/L phenyl-methylsulfonyl fluoride, 0.5 mmol/L
Na3VO4, and 5 g/mL aprotinin, leupeptin, and pepstatin for 15
minutes on ice. Cell lysates were cleared by centrifugation at
15 000g for 5 minutes and protein concentrations determined using
the BCA protein assay (Pierce). Cell proteins were separated by
SDS-PAGE, transferred to polyvinylidene difluoride (PVDF) mem-
branes (Millipore), immunoblotted and visualized by ECL (Amer-
sham Biosciences).
Fluorescence-Activated Cell Sorting Analysis
SMC were trypsinized, pooled with all detached cells from their
respective supernatants, and washed twice with ice-cold PBS.
Double staining with fluorescein isothiocyanate (FITC)-conjugated
annexin V and propidium iodide (PI) was performed according to the
protocol of the manufacturer (Beckman Coulter). Samples were
analyzed in a flow cytometer (Epics XL; Beckman Coulter) using the
software Expo32 ADC Analysis. For each determination, a minimum
of 10 000 events per sample was acquired.
Electrophoretic Mobility Shift Assay
SMC were plated on collagen 24 hours before treatment, and
electrophoretic mobility shift assays (EMSAs) were performed as
previously described.12 A double-stranded oligonucleotide contain-
ing the DNA-binding site for NF-B (5AGTTGAGGGGACTTTC-
CCAGGC3; Santa Cruz Biotechnology) was end-labeled using
[32P]ATP (ICN) and T4-PNK (MBI Fermentas). The lysed nuclei
were centrifuged for 5 minutes at 4°C 12 000g and diluted with 30
L of Buffer D (20 mmol/L Hepes, pH 8.0, 50 mmol/L KCl, 20%
glycerol, 0.2 mmol/L EDTA, 0.5 mmol/L phenylmethylsulfonyl
fluoride [PMSF], and 0.5 mmol/L dithiothreitol [DTT]). Ten micro-
grams of nuclear extracts were mixed with 60 000 to 80 000 cpm of
labeled probe in binding buffer (10 mmol/L Tris HCl, 1 mmol/L
EDTA, 1 mmol/L DTT, and 0.05% NP-40, pH 7.5) and 50 g/mL
poly dIdC and incubated at room temperature for 20 minutes. For
competition and supershift studies, unlabeled NF-B oligonucleo-
tides or unspecific p53mut oligonucleotides and antibodies against the
p50 and p65 subunits of NF-B (Santa Cruz Biotechnology),
respectively, were used.
Retroviral Infection
Human IBSer32,36/Ala was generated as previously described.13
Retroviral expression plasmids were constructed using the inter-
nal ribosomal entry site (IRES) vector pBMN-IRES-PURO ex-
pressing the puromycin resistance gene PAC as a selectable
second cistron gene.14 Amphotrophic retrovirus was prepared
using Phoenix-A packaging cells and transfections performed as
described previously.14 For selection, the retroviral supernatant
was replaced with growth medium containing puromycin (5 to 10
g/mL) 12 hours after transfection. Cells were cultured for
additional 48 hours before use.
Transfection of Small Interfering RNA
The small interfering RNAs (siRNAs) with the following sense and
antisense sequences were (1) for xIAP: sense, 5-GUGGUAGUCC-
UGUUUCAGCdTdT-3; and antisense, 5-GCUGAAACAGGACU-
ACCACdT dT-3; (2) for c-IAP2: sense, 5-GUUCAAGCCAGUU-
ACCCUCdTdT-3; and antisense 5-GAGGGUAACUGGCUUGA-
ACdTdT-3; (3) for survivin: sense, 5-GAGCCAAGAACAAAA-
UUGCdTdT-3; and antisense, 5-GCAAUUUUGUUCUUGGCU-
CdTdT-3; (4) for control (nonsilencing): sense, 5-UUCUCCGAA-
CGUGUCACGUdTdT-3; and antisense, 5-ACGUGACACGU-
UCGGAGAAdTdT-3. All siRNAs were purchased from Qiagen,
and transfections were performed using a transfection system (Bio-
Rad Laboratories) according to the protocol of the manufacturer.
Statistics
Results are given as meansSD. Comparisons between multiple
groups were performed using 1-way ANOVA followed by a Fisher’s
least-significant difference (LSD) post hoc test. Single comparisons
were made using Student t test. A probability value of P0.05 was
considered statistically significant.
Figure 2. Degraded collagen fragments
activate NF-B in human SMC. A, Cells
were incubated with or without 250
g/mL degraded type I collagen for the
indicated times, and NF-B activity was
determined by EMSA. B, To confirm
specificity of NF-B DNA binding, excess
unlabeled specific B oligonucleotide or
unspecific (p53mut) oligonucleotide were
added to nuclear extracts of SMC
treated with degraded collagen for 2
hours. Supershift analysis was performed
using antibodies against the p50 and
p65 subunits of NF-B. The proteasomal
inhibitors MG-132 (10 mol/L) and LLnL
(50 mol/L) were added 30 minutes
before the collagen fragments. C, Left,
SMC were treated with or without LLnL
(50 mol/L) in the presence of collagen
fragments for the indicated times and
immunoblotted for phospho-
IB(Ser32,36) and total IB. GAPDH
was used as a loading control. Right,
Quantification of phosphorylated IB as
fold increase after treatment with colla-
gen fragments for 6 hours (n3 experi-
ments). *P0.05 vs control.
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Results
Degraded Collagen Fragments Induce Apoptosis in
SMC in the Presence of Cycloheximide or
Proteasome Inhibition
We have recently shown that proteolytic fragments derived
from polymerized type I collagen gels rapidly activate
caspases and induce apoptosis in SMC and that this process is
dependent on calpains.11 Nevertheless, the majority of SMC
recovered and survived, with only 15.41.9% of the cells
having died after 24 hours of incubation with 250 g/mL type
I collagen fragments (Figure 1A). If, however, cycloheximide
or the proteasome inhibitor LLnL were added, apoptosis was
dramatically enhanced to 36.09.2% and 62.52.9%, re-
spectively (Figure 1A), with potent activation of caspase-3
and distinct cleavage of the caspase substrates PARP and
lamin A/C (Figure 1B and 1C). Thus we hypothesized that
collagen fragments activate simultaneously a death and a
survival pathway and tested whether the transcription factor
NF-B, known to promote survival in many experimental
systems, was involved.
Degraded Collagen Fragments Induce NF-B
Activation in SMC
EMSAs for NF-B showed a marked activation 1 hour after
exposure to 250 g/mL degraded collagen fragments that
remained constant up to 8 hours (Figure 2A) and declined
after 16 hours (data not shown). The NF-B DNA binding
activity was specific as it became undetectable in the pres-
ence of excess unlabeled specific oligonucleotide and was
unaltered by excess unspecific oligonucleotide (Figure 2B).
Preincubation of SMC with 2 different proteasome inhibitors
(LLnL and MG-132) abolished NF-B activation by de-
graded collagen fragments (Figure 2B). To test whether
NF-B was activated via phosphorylation and proteasomal
degradation of its inhibitor IB15 in our system, SMC were
exposed to degraded collagen in the presence or absence of
LLnL, and the levels of total and phosphorylated (Ser32,36)
IB were examined by Western blotting. Incubation with
degraded collagen fragments alone led to a rapid IB
phosphorylation and degradation (Figure 2C). In the presence
of LLnL, IB was also phosphorylated but accumulated
over time, suggesting that NF-B activation is mediated by
proteasomal IB degradation (Figure 2C).
NF-B Inhibition by Proteasomal Inhibitors and a
Superrepressor IBSer32,36/Ala Induces Apoptosis in
SMC Exposed to Degraded Collagen
Because activation of NF-B is protective against apoptosis in a
number of experimental systems, we tested whether the inhibi-
tion of IkB degradation by proteasome inhibitors was causally
involved in cytoprotection. To specifically inactivate NF-B, we
infected SMC with an IRES-PURO retrovirus encoding a
phosphorylation-resistant IB mutant (IBSer32,36/Ala) and the
selectable puromycin resistance gene. This allowed rapid selec-
tion of a transduced SMC population expressing IBSer32,36/Ala
with approximately 99% infection efficiency as we have previ-
ously shown.13,14 Transduced SMC containing the control vector
were treated with collagen fragments in the presence or absence
of LLnL, and SMC overexpressing IBSer32,36/Ala were treated
with collagen fragments alone (Figure 3). Although overexpres-
sion of IBSer32,36/Ala per se did not induce any morphological
changes, treatment with collagen fragments led to pronounced
cell rounding, blebbing and detachment reminiscent of apoptosis
(Figure 3A). Accordingly, Western blot analysis revealed dis-
tinct and specific cleavage of the caspase-6 substrate lamin A/C
in SMC overexpressing IBSer32,36/Ala after treatment with col-
lagen fragments (Figure 3B). In contrast, SMC transduced with
the control vector and treated with degraded collagen did not
show lamin A/C cleavage unless LLnL was present (Figure 3B).
Blockade of v3 Integrins Prevents NF-B
Activation and Leads to Apoptosis in the Presence
of Degraded Collagen
To test whether degraded collagen activates NF-B via
binding to specific integrins, SMC were incubated with
blocking antibodies against 2, 5 and v3 integrins, respec-
tively, and exposed to degraded collagen for 2 hours.
Whereas blockade of 2 and 5 integrins had no effects on
NF-B DNA binding activity in EMSAs (data not shown),
blocking antibodies to v3 substantially inhibited NF-B
activation by degraded collagen (Figure 4A). Blockade of
Figure 3. NF-B inhibition by proteasomal inhibitors or overex-
pression of superrepressor IBSer32,36/Ala induces apoptosis in
SMC exposed to degraded collagen. A, Phase-contrast micros-
copy of SMC infected with pBMN-IRES-PURO retrovirus encod-
ing a control vector (a through c) or IBSer32,36/Ala (d and e) and
treated with (b, c, and e) or without (a and d) degraded collagen
for 24 hours. The morphology of vector-transduced SMC
treated with degraded collagen and LLnL (50 mol/L) is shown
in c. Arrows indicate membrane blebbing as a morphological
marker for apoptosis. B, SMC were treated as described in A
and harvested after 24 and 36 hours of collagen fragment treat-
ment, respectively. Apoptosis was evaluated by immunoblotting
against cleaved lamin A/C. Total IB levels were determined by
immunoblotting, and -actin was used to confirm equal loading.
Shown is a representative experiment of 3.
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v3 in the absence of degraded collagen had no effect on
basal NF-B activity (Figure 4A). Furthermore, v3 block-
ade by anti-v3 antibodies and RGD peptides resulted in
enhanced apoptosis as shown by PARP and lamin A/C
cleavage and this was further enhanced by treatment with
LLnL (Figure 4B).
Degraded Collagen Induces IAP Expression via
Activation of NF-B
NF-B–dependent de novo gene expression is required for
survival in many experimental systems,16 and several mem-
bers of the IAP family are under its transcriptional control,
thereby mediating its antiapoptotic effects.17,18 To determine
whether IAPs may be involved in NF-B–mediated protec-
tion in our system, we analyzed their expression in SMC
exposed to degraded collagen. There was a rapid and potent
induction of xIAP, c-IAP2, and survivin after 1 hour of
collagen fragment treatment and their levels steadily in-
creased up to 30 hours (Figure 5A). To test whether IAP
induction was NF-B-dependent, we retrovirally overex-
pressed the superrepressor IBSer32,36/Ala and a control vector,
respectively, and determined IAP levels after incubation of
SMC with degraded collagen. The induction of xIAP and
c-IAP2 by collagen fragments was substantially inhibited in
IBSer32,36/Ala-expressing cells compared with control vector
transduced cells (Figure 5B). In control SMC, LLnL inhibited
the induction of xIAP and c-IAP2 by collagen fragments in a
comparable manner (Figure 5B).
Inhibition of IAPs by siRNA Sensitizes SMC to
Apoptosis in the Presence of Collagen Fragments
To test whether the induction of IAP expression in SMC after
exposure to degraded collagen is necessary for survival, we
knocked down IAP expression by siRNA. Initially, SMC
were transfected with siRNA against xIAP, c-IAP2 and
nonsilencing siRNA, respectively, and protein levels of the
IAPs were determined by Western blot analysis. A marked
reduction of xIAP and c-IAP2 protein expression was present
48 and 72 hours after siRNA treatment (Figure 6A), with no
effect on basal apoptosis rate (data not shown). We then
treated SMC with siRNA against xIAP, c-IAP2, or survivin
and exposed them to degraded collagen for 18 hours. We
observed that, in contrast to SMC treated with nonsilencing
siRNA, apoptosis was distinctly induced in all IAP-siRNA–
treated SMC, as shown by cleavage of lamin A/C, PARP and
activation of caspase-3 (Figure 6B). These results suggest that
the induction of IAPs is necessary and sufficient to protect
SMC against apoptosis after treatment with degraded
collagen.
Discussion
Type I Collagen Fragments Activate a Death and
a Survival Pathway via Different Integrins:
Functional Cross-Talk at the IAP Level
We have previously demonstrated that treatment of SMC
with collagen fragments leads to a rapid activation of
caspases and apoptosis via calpains.11 However, as this
process was moderate and the majority of the cells survived,
we postulated the existence of a survival pathway activated in
parallel by degraded collagen and dominating the calpain-
mediated apoptotic pathway. In the present study, we identi-
fied this survival pathway as the robust activation of NF-B
via phosphorylation and degradation of IB. Its causal
involvement was evident from the rapid submission of SMC
to apoptosis when NF-B activation was prevented by pro-
teasome inhibitors or a superrepressor IB. We have previ-
ously shown that 2 integrins mediate calpain activation by
degraded collagen in our system10 and have now identified
v3 integrins as responsible for NF-B activation by the
same collagen fragments. Blockade of v3 not only pre-
vented NF-B activation but also resulted in apoptosis in the
Figure 4. Blockade of v3 integrins pre-
vents NF-B activation and leads to apopto-
sis in the presence of degraded collagen. A,
Left, SMC were preincubated for 30 minutes
with a blocking antibody against v3 integrin
(10 g/mL per 500 000 cells) and exposed
to degraded collagen for 2 hours. To
exclude an effect on basal NF-B activity,
SMC were incubated with the antibody in
the absence of degraded collagen for 2
hours. EMSA was performed as in Figure 2.
Tumor necrosis factor- (TNF)-treated (50
ng/mL) SMC were used as a positive con-
trol. Shown is a representative experiment of
4. Right, NF-B DNA binding activity was
quantified densitometrically by NIH Image
and presented as fold increase over
untreated SMC. *P0.05. B, SMC were
incubated with 10 g/mL blocking v3 anti-
body and 100 mol/L RGD peptides in the
presence or absence of 50 mol/L LLnL and
exposed to collagen fragments for 24 hours.
A nonblocking isotype-matched mouse IgG1
was used as control. Apoptosis was evalu-
ated by immunoblotting against PARP and
cleaved lamin A/C. -Actin was used as
loading control. Shown is a representative
experiment of 3.
1494 Circulation Research June 23, 2006
D
ow
nloaded from
 http://ahajournals.org by on September 27, 2019
presence of collagen fragments, suggesting that v3 integrins
promote survival via induction of NF-B in our system.
Engagement of v3 by ECM plays an important role in
survival in several vascular cell types: (1) it protects endo-
thelial cells against apoptosis after binding to osteopontin or
fibronectin via NF-B19 –21; (2) its ligation by MMP-
generated type I collagen fragments promotes survival in rat
vascular SMC through tenascin-C9,22,23; and (3) MMPs se-
creted by human SMC cultured on polymerized collagen gels
generate fragments capable of inducing NF-B–dependent
transcription.13 Together, these data suggest that in our
system, degraded collagen fragments simultaneously acti-
vated an apoptotic pathway triggered by 2-mediated calpain/
caspase activation and a survival pathway triggered by
v3-mediated NF-B activation (Figure 7). The survival
pathway was dominant over the apoptotic as substantial cell
death took place only after inactivation of NF-B. One
possibility of a functional cross-talk between these 2 rival
pathways may be at the level of the IAPs: whereas calpains
proteolytically destroyed xIAP leading to loss of its caspase-
inhibitory potential,11 several IAPs including xIAP were
potently induced by NF-B. Such dynamic modulations of
IAP levels inside the cell may have a substantial impact on
the activation threshold of caspases as autoprocessing and
activation of caspases is known to occur in the absence of the
IAPs.24 Thus the functional dominance of the survival path-
way over the apoptotic may be anchored in its ability to
elevate the IAP threshold for caspase activation (Figure 7).
An additional survival mechanism in our system may be
mediated by Akt as collagen fragments activated Akt and
were more effective in promoting apoptosis when Akt was
inhibited (data not shown).
Our siRNA experiments have suggested that several IAPs
were causally and independently responsible for survival as
Figure 5. Degraded collagen fragments induce IAPs in an
NF-B–dependent manner. A, Whole cell extracts prepared
from cells incubated with degraded collagen fragments for the
indicated times were immunoblotted with antibodies against
xIAP, c-IAP2, and survivin. -Actin was used as loading control.
Induction of IAP expression after 24 hours of treatment was
quantified using NIH Image. Results are presented as meanSD
from 5 independent experiments. *P0.05 vs control. B, SMC
were infected with control PURO vector or IBSer32,36/Ala and
treated as described in Figure 2C. Protein levels of xIAP and
c-IAP2 were determined by immunoblotting. -Actin was used
as loading control. Shown is a representative experiment of 3.
Figure 6. Collagen fragments induce apoptosis after siRNA
treatment against IAPs. A, SMC were transfected with specific
siRNA against xIAP, c-IAP2, or nonsilencing control siRNA, and
IAP expression was analyzed by Western blotting 48 and 72
hours later. Shown is a representative experiment of 4. B, SMC
were treated with siRNAs as in A and exposed to collagen frag-
ments for 18 hours. Apoptosis was determined by immunoblot-
ting with antibodies against cleaved lamin A/C, PARP, and
active caspase-3. -Actin was used as loading control. Shown
is a representative experiment of 3.
Figure 7. Schematic of a putative crosstalk between the
calpain-mediated apoptotic pathway and the NF-B–mediated
survival pathway in SMC exposed to degraded collagen. The
impact of both pathways on the IAP threshold for caspase acti-
vation may determine the sensitivity of SMC for apoptosis in the
presence of degraded collagen.
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reducing the levels of single ones such as xIAP, c-IAP2, or
survivin was sufficient to induce apoptosis. The inability to
compensate or substitute for the antiapoptotic potential of one
another suggests that individual IAPs play unique, nonredun-
dant roles in our system. This is in line with the existence of
several antiapoptotic functions beyond caspase inhibition of
the individual IAPs such as the E3-ubiquitin ligase activity of
xIAP toward active caspase-3 and -9,25,26 and that of c-IAP2
toward caspase-7,27 as well as the activation of the c-Jun
N-terminal kinase-1 (JNK1) by xIAP but not c-IAP1 or
c-IAP2, and its necessity for the antiapoptotic activity of
xIAP.28 In SMC, high-density cultures have been shown to
exhibit high constitutive NF-B activity and increased resis-
tance to apoptosis attributable to enhanced expression of
c-IAP1.29 In endothelial cells, we and others have shown that
IAPs such as xIAP were not only regulated by NF-B but,
vice versa, activated NF-B themselves, thereby promoting
their own transcription.30,31 Thus, in our system, apart from
directly inhibiting caspases, IAPs may be also enforcing
survival through a positive feedback loop between their
NF-B–dependent transcription and their ability to, in turn,
activate NF-Bs themselves.30,31
ECM Degradation in the Atherosclerotic Lesion:
Pathways of SMC Death and Survival in a
Proteolytic Environment
Apoptotic SMC are found in atherosclerotic lesions, and the
low SMC numbers present in the thin fibrous caps of
vulnerable plaques imply that SMC death may have occurred
there over time. Eventually, such loss of SMC may poten-
tially lead to decreased collagen synthesis in the fibrous cap
and thus contribute to plaque destabilization and rupture.32,33
Increased type I collagen proteolysis by activated MMPs is
also considered a risk factor for plaque rupture34 and has been
shown to colocalize with MMPs in vulnerable plaques.2,35,36
However, little is known about the particular type I collagen
fragments generated in the atherosclerotic plaque in vivo:
although the main type I collagen digesting enzymes such as
MMP-1, -8, and -13 are abundantly present and active in the
lesion, the only in vivo identified collagen fragments are
those exposing the neoepitope generated after cleavage of the
native triple-helical fibrils of type I, II, and III collagen at the
collagenase-specific single site Gly775-Leu/Ile776.35,36 Ac-
cording to well-established biochemical in vitro evidence, the
resulting three-fourths and one-fourth collagen fragments
would become accessible substrates to other MMPs present in
the lesion such as gelatinases and stromelysins and be further
catabolized.37,38 Besides the MMPs, there is another class of
collagen-degrading enzymes present in the atherosclerotic
lesion, the cathepsins, and these are known to cleave type I
collagen in vitro at sites that are different from those cleaved
by the MMPs: cathepsins L and B cleave only telopeptides
but not the native type I collagen triple helix, whereas
cathepsin K cleaves both telopeptides at multiple sites within
the triple helix.39–41 Therefore, it is more than plausible that
several different collagen fragments are present simulta-
neously and/or consecutively in the atherosclerotic plaque in
vivo. The v3 integrin is also present in lesions of athero-
sclerosis and appears to crucially influence the SMC content
of the neointima after injury by regulating SMC migration.42
As SMC degrade ECM during migration, this may be 1
possible scenario of a proteolytic environment where ECM
fragments influence SMC survival by engaging v3.
Macrophages and SMC are often neighbors in the athero-
sclerotic plaque, thereby actively interacting and influencing
each other’s biological behavior.43,44 Because of this neigh-
borhood, plaque SMC will most likely be confronted with
matrix degradation, eg, by excessive production of MMPs by
macrophages, at some point of their life. In a proteolytic
environment, where protective outside-in signals from inte-
grins are interrupted by the degradation of their ECM ligands,
the existence of an antiapoptotic pathway originating pre-
cisely from some of the arising proteolytic ECM fragments
may be important to guarantee SMC survival. Interestingly,
apoptosis of SMC induced by mast cell chymase or
lymphocyte-derived granzyme B in vitro have both been
attributed to degradation of their fibronectin matrix and
consecutive loss of protective focal adhesion signals.45,46 In
the much more complex microenvironment of atherosclerotic
lesions, the presence of type I collagen fragments may
counteract such apoptotic signals. Furthermore, high IAP
levels maintained by collagen fragments may also protect
SMC against other apoptotic stimuli present in the lesion such
as reactive oxygen species, Fas, p53, and deadly cytokines.5,6
In conclusion, our finding that collagen fragments tightly
regulate SMC survival may be pathophysiologically essential
not only at sites of increased ECM proteolysis such as
atherosclerotic plaques but also in biological settings where
ECM degradation is a general phenomenon necessary for cell
migration, vascular remodeling, and neointima formation.47,48
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